Article metrics

Original research
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

 

Online download statistics by month:

Online download statistics by month: March 2021 to May 2022

AbstractFullPdf
Mar 2021654654213
Apr 2021659659189
May 202142542554
Jun 202115715729
Jul 202113913946
Aug 202113013023
Sep 202123623641
Oct 202112712749
Nov 202113713836
Dec 202114714739
Jan 202212713043
Feb 202210410737
Mar 2022687229
Apr 2022464718
May 2022666624
Total32223234870